Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

February 12th marks the 75th anniversary of the first therapeutic dose of penicillin being administered to Albert Alexander in 1941, a policeman in the Radcliffe Infirmary on Woodstock Road.

© r.classen - Shutterstock

Image courtesy of Shutterstock

Its link to the penicillin story has given the Dunn School one of the permanent top spots in the annals of biomedical history. 

Head of Department, Matthew Freeman said:  "this was the birth of the antibiotic era and, unsurprisingly, was recently voted as the greatest medical discovery of the 20th century.  It’s a great story (though sadly Albert Alexander died because they did not have enough penicillin for a complete course)."

Find out more (Sir William Dunn School of Pathology website)

Similar stories

Oxford vaccine reaches one billion doses released

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.

Research programme tackling COVID-19 variants of concern receives funding boost

A gift from the Red Avenue Foundation will enable the expansion of a major research programme aimed at rapidly identifying and interrogating emerging COVID-19 variants.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.